IGM Biosciences, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (10)

Latest Posts

About This Stock More About This Stock
Tech-Heavy Nasdaq Firmly Higher Midday
Article By: Schaeffers Research
Thursday, June 22, 2023 12:26 PM EDT
Stocks are attempting a rebound this afternoon, following their third-straight day of losses.
In this article: WAL, QQQ, SPX, VIX, DJI, IGMS, CDMO
Read
Stocks Higher As Ukraine-Russia Peace Talks Advance
Article By: Schaeffers Research
Tuesday, March 29, 2022 12:27 PM EDT
Optimism is high on Wall Street, as peace talks between Ukraine and Russia seem to advance.
In this article: PFE, QQQ, MRNA, SPX, VIX, DJI, NEO, IGMS, FUBO
Read
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
Article By: Tyler Durden
Wednesday, June 2, 2021 1:47 PM EDT
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more stimmy power.
In this article: DDS, GEO, IVC, INO, DMTK, BBBY, ESPR, RNA, GOGO, GTT, FLGT, WKHS, IGMS, OTRK
Read
Short Interest Through The End Of March
Article By: Bespoke Investment Group
Thursday, April 15, 2021 1:04 AM EDT
ln aggregate for Russell 3,000 stocks, short interest as a percent of equity float is little changed versus where it stood in mid-March. But on an industry basis, there have been some large moves.
In this article: RKT, SEAC, DISCA, GOGO, IGMS, SUMO, RXT, ASO, FREQ, ITOS
Read
Week In Review: I-Mab Seeking $2 Billion Deal For CD-47 Candidate
Article By: ChinaBio® Today
Saturday, May 2, 2020 3:58 PM EDT
I-Mab BioPharma of Shanghai is shipping its CD-47 immunoncology candidate to various global biopharmas with hopes of forming a $2 billion collaboration. I-Mab believes TJC4 is a potential global CD47 because it binds to a unique epitope on CD47.
In this article: BAYRY, BCEL, BGNE, IGMS
Read

Latest Tweets for $IGMS

No tweets yet!

PARTNER HEADLINES